Molecular Medicine Israel

Natural Products as a Source for Novel Antibiotics

Natural products have historically been of crucial importance in the identification and development of antibacterial agents. Interest in these systems has waned in recent years, but the rapid emergence of resistant bacterial strains has forced their re-evaluation as a route to identify novel chemical skeletons with antibacterial activity for elaboration in drug development. This overview examines the current situation, highlights new natural product systems which have been found, together with re-examination of some old ones, and new technologies for their identification. While natural products certainly have the potential to re-emerge as a key start-point in antibacterial drug discovery, reports of new or reinvestigated structures need to be supported with sufficient quality chemical (solubility, stability), biochemical (including toxicity in particular, along with target information) and microbiological [minimum inhibitory concentration (MIC) and resistance frequency] validation data to assist in the identification of promising hit structures and to avoid wasted effort from trawling over already cultivated territory. This is particularly important in a resource-limited research environment.


Although the emergence of AMR has strained drug discovery efforts, natural products chemistry has been de-emphasised relative to other approaches.

Natural products continue to provide new chemical structures with high levels of antibacterial activity.

New methodologies for the cultivation of bacteria and the identification of novel natural products offer opportunities not previously possible.

An excellent example of the value of the use of natural products as start-points for antibacterial discovery comes from the detailed examination of the viridicatumtoxins, which provide inspiration for new tetracycline antibiotics, and of colistin, which provides new-generation polymixin systems.

The structural modularity of many natural product-derived antibacterials allows a building-block approach which can be exploited for the rapid construction of new chemical systems.

Reinvigoration of this approach is fully justified as a fast route to address the AMR problem.

Sign up for our Newsletter